Hansen BS - Search Results

1

Adenosine is an agonist of the growth hormone secretagogue receptor.

Tullin S, Hansen BS, Ankersen M, Møller J, Von Cappelen KA, Thim L. Tullin S, et al. Among authors: hansen bs. Endocrinology. 2000 Sep;141(9):3397-402. doi: 10.1210/endo.141.9.7631. Endocrinology. 2000. PMID: 10965912

2

Ipamorelin, the first selective growth hormone secretagogue.

Raun K, Hansen BS, Johansen NL, Thøgersen H, Madsen K, Ankersen M, Andersen PH. Raun K, et al. Among authors: hansen bs. Eur J Endocrinol. 1998 Nov;139(5):552-61. doi: 10.1530/eje.0.1390552. Eur J Endocrinol. 1998. PMID: 9849822

3

Pharmacological characterisation of a new oral GH secretagogue, NN703.

Hansen BS, Raun K, Nielsen KK, Johansen PB, Hansen TK, Peschke B, Lau J, Andersen PH, Ankersen M. Hansen BS, et al. Among authors: hansen tk. Eur J Endocrinol. 1999 Aug;141(2):180-9. doi: 10.1530/eje.0.1410180. Eur J Endocrinol. 1999. PMID: 10427162

4

The influence of conformational restriction in the C-terminus of growth hormone secretagogues on their potency.

Peschke B, Ankersen M, Bauer M, Hansen TK, Hansen BS, Nielsen KK, Raun K, Richter L, Westergaard L. Peschke B, et al. Among authors: hansen bs, hansen tk. Eur J Med Chem. 2002 Jun;37(6):487-501. doi: 10.1016/s0223-5234(02)01370-3. Eur J Med Chem. 2002. PMID: 12204475

5

Parallel solid-phase synthesis of disubstituted (5-biphenyltetrazolyl) hydantoins and thiohydantoins targeting the growth hormone secretagogue receptor.

Severinsen R, Lau JF, Bondensgaard K, Hansen BS, Begtrup M, Ankersen M. Severinsen R, et al. Among authors: hansen bs. Bioorg Med Chem Lett. 2004 Jan 19;14(2):317-20. doi: 10.1016/j.bmcl.2003.11.012. Bioorg Med Chem Lett. 2004. PMID: 14698149

6

New highly potent dipeptidic growth hormone secretagogues with low molecular weight.

Peschke B, Ankersen M, Hansen TK, Hansen BS, Lau J, Nielsen KK, Raun K. Peschke B, et al. Among authors: hansen bs, hansen tk. Eur J Med Chem. 2000 Jun;35(6):599-618. doi: 10.1016/s0223-5234(00)00160-4. Eur J Med Chem. 2000. PMID: 10906412

7

Highly potent growth hormone secretagogues: hybrids of NN703 and ipamorelin.

Hansen TK, Ankersen M, Raun K, Hansen BS. Hansen TK, et al. Among authors: hansen bs. Bioorg Med Chem Lett. 2001 Jul 23;11(14):1915-8. doi: 10.1016/s0960-894x(01)00345-6. Bioorg Med Chem Lett. 2001. PMID: 11459660

8

A new series of highly potent growth hormone-releasing peptides derived from ipamorelin.

Ankersen M, Johansen NL, Madsen K, Hansen BS, Raun K, Nielsen KK, Thogersen H, Hansen TK, Peschke B, Lau J, Lundt BF, Andersen PH. Ankersen M, et al. Among authors: hansen bs, hansen tk. J Med Chem. 1998 Sep 10;41(19):3699-704. doi: 10.1021/jm9801962. J Med Chem. 1998. PMID: 9733495

9

Novel orally active growth hormone secretagogues.

Hansen TK, Ankersen M, Hansen BS, Raun K, Nielsen KK, Lau J, Peschke B, Lundt BF, Thøgersen H, Johansen NL, Madsen K, Andersen PH. Hansen TK, et al. Among authors: hansen bs. J Med Chem. 1998 Sep 10;41(19):3705-14. doi: 10.1021/jm980197u. J Med Chem. 1998. PMID: 9733496

10

Recognition of privileged structures by G-protein coupled receptors.

Bondensgaard K, Ankersen M, Thøgersen H, Hansen BS, Wulff BS, Bywater RP. Bondensgaard K, et al. Among authors: hansen bs. J Med Chem. 2004 Feb 12;47(4):888-99. doi: 10.1021/jm0309452. J Med Chem. 2004. PMID: 14761190

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

135 results

Search Page